Show simple item record

dc.contributor.authorWandera, Ernest Apondi Wandera
dc.contributor.authorMohammad, Shah
dc.contributor.authorBundi, Martin
dc.contributor.authorNyangao, James
dc.contributor.authorGalata, Amina
dc.contributor.authorKathiiko, Cyrus
dc.contributor.authorOdoyo, Erick
dc.contributor.authorGuyo, Sora
dc.contributor.authorMiring’u, Gabriel
dc.contributor.authorKomoto, Satoshi
dc.contributor.authorIchinose, Yoshio
dc.date.accessioned2018-06-02T09:37:00Z
dc.date.available2018-06-02T09:37:00Z
dc.date.issued2018-04
dc.identifier.citationTropical Medicine and International Healthen_US
dc.identifier.uridoi:10.1111/tmi.13040
dc.identifier.urihttp://hdl.handle.net/123456789/1470
dc.descriptionfull texten_US
dc.description.abstractA two-dose oral monovalent rotavirus vaccine (RV1) was introduced into the KenyanNational Immunization Program in July 2014. We assessed trends in hospitalisation for rotavirus-specific acute gastroenteritis (AGE) and strain distribution among children <5 years in a rural,resource-limited setting in Kenya before and after the nationwide implementation of the vaccine.methods Data on rotavirus AGE and strain distribution were derived from a 5-year hospital-basedsurveillance. We compared rotavirus-related hospitalisations and strain distribution in the 2-yearpost-vaccine period with the 3-year pre-vaccine baseline. Vaccine administrative data from the Unitof Vaccines and Immunization Services (UVIS) for Mbita sub-county were used to estimate rotavirusimmunisation coverage in the study area.results We observed a 48% (95% CI: 27–64%) overall decline in rotavirus-related hospitalisationsamong children aged <5 years in the post-vaccine period. Coverage with the last dose of rotavirusvaccine increased from 51% in year 1% to 72% in year 2 of the vaccine implementation.Concurrently, reductions in rotavirus hospitalisations increased from 40% in the first year to 53% inthe second year of vaccine use. The reductions were most pronounced among the vaccine-eligiblegroup, with the proportion of cases in this age group dropping to 14% in post-vaccine years from ahigh of 51% in the pre-vaccine period. A diversity of rotavirus strains circulated before theintroduction of the vaccine with G1P[8] being the most dominant strain. G2P[4] replaced G1P[8] asthe dominant strain after the vaccine was introduced.conclusions Rotavirus vaccination has resulted in a notable decline in hospital admissions forrotavirus infections in a rural resource-limited population in Kenya. This provides early evidence forcontinued use of rotavirus vaccines in routine childhood immunisations in Kenya. Our data alsounderscore the need for expanding coverage on second dose so as to maximise the impact of the vaccine.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.relation.ispartofseriesvolume 23 no 4 pp 425–432;pp 425–432
dc.subjectrotavirus, gastroenteritis, vaccine impact, Kenyaen_US
dc.titleImpact of rotavirus vaccination on rotavirus hospitalisationrates among a resource-limited rural population in Mbita,Western Kenyaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record